276 related articles for article (PubMed ID: 18003778)
1. Removal of heparan sulfate from the glomerular basement membrane blocks protein passage.
Wijnhoven TJ; Lensen JF; Wismans RG; Lefeber DJ; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Dec; 18(12):3119-27. PubMed ID: 18003778
[TBL] [Abstract][Full Text] [Related]
2. In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria.
Wijnhoven TJ; Lensen JF; Wismans RG; Lamrani M; Monnens LA; Wevers RA; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Mar; 18(3):823-32. PubMed ID: 17251387
[TBL] [Abstract][Full Text] [Related]
3. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
Garin EH; Shirey AJ
Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate staining of the glomerular basement membrane in relation to circulating anti-DNA and anti-heparan sulfate reactivity: a longitudinal study in NZB/W F1 mice.
Hylkema MN; van Bruggen MC; van de Lagemaat R; Kramers K; Berden JH; Smeenk RJ
J Autoimmun; 1996 Feb; 9(1):41-50. PubMed ID: 8845053
[TBL] [Abstract][Full Text] [Related]
5. Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin.
Rosenzweig LJ; Kanwar YS
Lab Invest; 1982 Aug; 47(2):177-84. PubMed ID: 6213815
[No Abstract] [Full Text] [Related]
6. Polycation binding to glomerular basement membrane. Effect of biochemical modification.
Bertolatus JA; Hunsicker LG
Lab Invest; 1987 Feb; 56(2):170-9. PubMed ID: 3807316
[TBL] [Abstract][Full Text] [Related]
7. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
[TBL] [Abstract][Full Text] [Related]
8. Breaking down the barrier: evidence against a role for heparan sulfate in glomerular permselectivity.
Harvey SJ; Miner JH
J Am Soc Nephrol; 2007 Mar; 18(3):672-4. PubMed ID: 17301187
[No Abstract] [Full Text] [Related]
9. Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis.
van Bruggen MC; Kramers K; Hylkema MN; van den Born J; Bakker MA; Assmann KJ; Smeenk RJ; Berden JH
Am J Pathol; 1995 Mar; 146(3):753-63. PubMed ID: 7534044
[TBL] [Abstract][Full Text] [Related]
10. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats.
Mynderse LA; Hassell JR; Kleinman HK; Martin GR; Martinez-Hernandez A
Lab Invest; 1983 Mar; 48(3):292-302. PubMed ID: 6219248
[TBL] [Abstract][Full Text] [Related]
11. Vessel wall heparan sulfate and transcapillary passage of albumin in experimental diabetes in the rat.
van den Born J; van Kraats AA; Hill S; Bakker MA; Berden JH
Nephrol Dial Transplant; 1997; 12 Suppl 2():27-31. PubMed ID: 9269696
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate--rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome.
Vernier RL; Klein DJ; Sisson SP; Mahan JD; Oegema TR; Brown DM
N Engl J Med; 1983 Oct; 309(17):1001-9. PubMed ID: 6225948
[TBL] [Abstract][Full Text] [Related]
13. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
[TBL] [Abstract][Full Text] [Related]
14. [Glycosaminoglycan-glomerular basement membrane interactions revealed by affinity chromatography (author's transl)].
Lubec G
Padiatr Padol; 1982; 17(3):591-6. PubMed ID: 7110738
[TBL] [Abstract][Full Text] [Related]
15. Glycosaminoglycans of the glomerular basement membrane in normal and nephrotic states.
Kanwar YS; Rosenzweig LJ; Kerjaschki DI
Ren Physiol; 1981; 4(2-3):121-30. PubMed ID: 7302362
[TBL] [Abstract][Full Text] [Related]
16. Is microalbuminuria in diabetes due to changes in glomerular heparan sulphate?
van den Born J; Berden JH
Nephrol Dial Transplant; 1995; 10(8):1277-9. PubMed ID: 8538909
[No Abstract] [Full Text] [Related]
17. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains.
Wijnhoven TJ; Geelen JM; Bakker M; Lensen JF; Rops AL; Kramer AB; Navis G; van den Hoven MJ; van der Vlag J; Berden JH; Wetzels JF; van den Heuvel LP; Monnens LA; van Kuppevelt TH
Nephrol Dial Transplant; 2007 Oct; 22(10):2886-93. PubMed ID: 17526541
[TBL] [Abstract][Full Text] [Related]
18. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo.
Kramers C; Hylkema MN; van Bruggen MC; van de Lagemaat R; Dijkman HB; Assmann KJ; Smeenk RJ; Berden JH
J Clin Invest; 1994 Aug; 94(2):568-77. PubMed ID: 8040312
[TBL] [Abstract][Full Text] [Related]
19. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria.
Raats CJ; Van Den Born J; Berden JH
Kidney Int; 2000 Feb; 57(2):385-400. PubMed ID: 10652015
[TBL] [Abstract][Full Text] [Related]
20. Characterization of heparan sulfate isolated from drug glomerular basement membranes.
Linker A; Hovingh P; Kanwar YS; Farquhar MG
Lab Invest; 1981 Jun; 44(6):560-5. PubMed ID: 6453253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
